{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:56:45Z","timestamp":1773273405892,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vetimm.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T14:02:08Z","timestamp":1326549728000},"page":"597-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma"],"prefix":"10.1016","volume":"145","author":[{"given":"L.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Dow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Slansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2012.01.006_bib0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","article-title":"Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome","volume":"19","author":"Ansell","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetimm.2006.12.002","article-title":"Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer","volume":"116","author":"Biller","year":"2007","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1939-1676.2010.0557.x","article-title":"Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma","volume":"24","author":"Biller","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nm0307-250","article-title":"Regulatory T-cell development: is Foxp3 the decider?","volume":"13","author":"Curiel","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1471-2407-10-256","article-title":"Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates","volume":"10","author":"Estrela-Lima","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vetimm.2012.01.006_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-2427(01)00337-3","article-title":"Lymphocyte subsets in peripheral blood of dogs \u2013 a flow cytometric study","volume":"82","author":"Faldyna","year":"2001","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0035","article-title":"Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma","author":"Gerdemann","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0040","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.177.2.896","article-title":"Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells","volume":"177","author":"Jarnicki","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0045","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2003-06-2070","article-title":"New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population","volume":"103","author":"Jedema","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2012.01.006_bib0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20100269","article-title":"Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy","volume":"208","author":"Ma","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0055","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/0008-5472.CAN-11-0753","article-title":"Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors","volume":"71","author":"Mattarollo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0060","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.0902850","article-title":"Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors","volume":"184","author":"Merlo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/blood.V88.2.580.bloodjournal882580","article-title":"Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma","volume":"88","author":"Nelson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2012.01.006_bib0070","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.170.10.4905","article-title":"Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells","volume":"170","author":"Nowak","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/104063871002200317","article-title":"Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma","volume":"22","author":"Tominaga","year":"2010","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1476-5829.2009.00200.x","article-title":"Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0) \u2013 a Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"8","author":"Vail","year":"2010","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1939-1676.2006.tb02866.x","article-title":"Effects of chemotherapy on immune responses in dogs with cancer","volume":"20","author":"Walter","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0090","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2141.2001.02649.x","article-title":"Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study","volume":"112","author":"Xu","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0095","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2012.01.006_bib0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vetimm.2012.01.006_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242712000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242712000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:21:18Z","timestamp":1759044078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242712000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":21,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0165242712000098"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2012.01.006","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2012.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}